Ubs Group Ag Bio Affinity Technologies, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.76 - $3.0 $16,880 - $28,773	9,591 New	9,591 $20,000
Q3 2023 Nov 09, 2023	SELL	$0.99 - $1.9 $29 - $57	-30 Reduced 31.58%	65 $0
Q2 2023 Aug 11, 2023	SELL	$1.56 - $2.05 $3,609 - $4,743	-2,314 Reduced 96.06%	95 $0
Q1 2023 May 12, 2023	SELL	$1.52 - $3.06 $6,341 - $12,766	-4,172 Reduced 63.39%	2,409 $4,000
Q4 2022 Feb 08, 2023	BUY	$1.6 - $3.14 $2,652 - $5,206	1,658 Added 33.68%	6,581 $10,000
Q3 2022 Nov 10, 2022	BUY	$2.11 - $8.3 $10,387 - $40,860	4,923 New	4,923 $14,000

468K

Ticker BIAF
Exchange
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 2,727,580
Market Cap $3.35M
Description
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.